German Heart Institute
31
5
6
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 31 trials
100.0%
+13.5% vs industry average
6%
2 trials in Phase 3/4
0%
0 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (31)
Determination of the Prevalence of Unrecognized Heart Failure Among Patients at Risk in Urban Areas Across Germany Using CMR
Role: lead
Personalized Atrial Fibrillation Ablation Guided by Non-Invasive Global Mapping
Role: lead
Use of Stress-CMR Using Regadenoson and GE-267 in Adult Patients with Known or Suspected Coronary Artery Disease
Role: lead
"HerzCheck" - Detection of Early Heart Failure Using Telemedicine in Structurally Weak Regions
Role: lead
Magnetocardiography as a Diagnostic Screening Tool for Myocarditis and Other Types of Cardiomyopathy
Role: lead
Microvascular Cardiac Allograft Vasculopathy Trial
Role: lead
TAVI PACER: A Two-step Risk Score for Prediction of Permanent Pacemaker Implantation After TAVI.
Role: lead
Mobile and Digital Application in Heart Failure Networks Berlin/Brandenburg
Role: lead
Robotic-assisted Exercise Training in Heart Failure With Reduced Ejection Fraction
Role: lead
Early Versus Emergency Left Ventricular Assist Device Implantation in Patients Awaiting Cardiac Transplantation
Role: lead
Validation of a Non-invasive Assessment of Central Venous Oxygen Saturation by Using MRI
Role: lead
Cardiac Magnetic Resonance Tomography for Heart Failure With Preserved Ejection Fraction
Role: lead
Robotic-assisted Exercise Training in Heart Failure
Role: lead
Effect of Prescribed Cardiac Rehabilitation in Patients With Advanced Heart Failure or Ventricular Assist Device
Role: lead
Sunitinib Treatment on Tissue Sodium Accumulation (TSS2)
Role: collaborator
Validation of a Novel, Non-Dimensional Approach for Estimation of Pressure Gradients in Aortic Stenosis
Role: lead
CPVI Alone Versus. CPVI Plus Electrophysiological Substrate Ablation in the LA During SR for the Treatment of Non-PAF
Role: collaborator
Comparison of Different Frailty Assessment Tools
Role: lead
Personalised Decision Support for Heart Valve Disease
Role: lead
Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography Imaging(PARADIGM)
Role: collaborator